Search for Clinical Trial Results

Sponsored By

Cushing Syndrome - 25 Studies Found

Status Study
Recruiting Study Name: A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing Syndrome
Date: 2017-02-06
Interventions:
  • Drug: ATR-101 During the 4-wee
Completed Study Name: Long Term Post Operative Follow-Up of Cushing Syndrome
Condition: Cushing Syndrome
Date: 2002-01-26
Completed Study Name: Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome
Condition: Cushing's Syndrome
Date: 1999-11-03
Enrolling by invitation Study Name: Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome
Condition: Cushing's Syndrome
Date: 2016-01-08
Interventions: Other: No intervention No treatment (intervention) was administered.
Completed Study Name: An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Date: 2009-07-09
Interventions: Drug: mifepristone Mifepristone 300 mg to 1200 mg once daily
Recruiting Study Name: Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Condition: Cushing's Syndrome
Date: 2016-06-15
Interventions: Drug: CORT125134
Completed Study Name: A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Date: 2007-12-05
Interventions: Drug: mifepristone Patients take mifepristone by mouth once a day. The dose is increased during schedule
Recruiting Study Name: Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Date: 2013-12-21
Interventions:
  • Drug: F-DOPA PET Scan
  • Drug: Mifepristone
Recruiting Study Name: Saliva Cortisol Measurement as a Screening Test for Suspicious Cushings Syndrome in Children.
Condition: Cushings Syndrome
Date: 2016-01-04
Interventions: Other: Children refered to the obesity clinic Compere if urine cortisol is as good as saliva cortisol as
Terminated Study Name: Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Condition: Cushing's Syndrome
Date: 2007-01-12
Interventions: Drug: Mifepristone Singe dose
Next >>>